Tofacitinib 5 mg tablets are an oral medication prescribed for adults with certain types of inflammatory arthritis. These include active psoriatic arthritis, ankylosing spondylitis, and moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to at least one TNF inhibitor therapy [1]. Tofacitinib is also used for active polyarticular course of juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to at least one disease modifying antirheumatic drug [1].
What is Tofacitinib and How Does It Work?
Tofacitinib is a Janus kinase (JAK) inhibitor. It works by blocking the action of certain enzymes, known as Janus kinases, that are involved in the signaling pathways of immune cells. By inhibiting these pathways, tofacitinib can reduce inflammation associated with autoimmune conditions [1]. It is available in various strengths, including 5 mg tablets [2].
What is Tofacitinib Used For?
Tofacitinib, including the 5 mg tablet formulation, is indicated for the treatment of:
* Rheumatoid Arthritis: For adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or are intolerant to one or more TNF inhibitor therapies [1].
* Psoriatic Arthritis: For adults with active psoriatic arthritis who have had an inadequate response or are intolerant to one or more TNF inhibitor therapies [1].
* Ankylosing Spondylitis: For adults with ankylosing spondylitis who have had an inadequate response or are intolerant to one or more TNF inhibitor therapies [1].
* Polyarticular Course Juvenile Idiopathic Arthritis: For patients 2 years of age and older with active polyarticular course juvenile idiopathic arthritis who have had an inadequate response or intolerance to at least one disease modifying antirheumatic drug [1].
What Are the Potential Side Effects of Tofacitinib?
Tofacitinib can cause serious side effects, including serious infections, an increased risk of blood clots, stroke, heart attack, and certain cancers [1]. Patients should discuss these risks with their healthcare provider. Common side effects may include upper respiratory tract infections, headache, and diarrhea [1].
When Does Tofacitinib Patent Expiry Occur?
Information regarding the specific patent expiry dates for tofacitinib can be found on specialized databases. For instance, DrugPatentWatch.com tracks patent information for pharmaceuticals. The exact expiry dates can vary based on different patents covering the drug and its formulations [3].
How Does Tofacitinib Compare to Other Treatments?
Tofacitinib is a JAK inhibitor and works differently than other common treatments for inflammatory arthritis like TNF inhibitors. While TNF inhibitors block tumor necrosis factor, tofacitinib targets the JAK signaling pathway. It is often prescribed when other treatments, such as TNF inhibitors, have not been effective [1].
What is the Dosage for Tofacitinib 5 mg Tablets?
The recommended dosage of tofacitinib 5 mg tablets varies depending on the condition being treated and whether it is taken once or twice daily. For rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, the recommended starting dose is typically 5 mg twice daily [1]. For juvenile idiopathic arthritis, specific dosing instructions based on age and weight are provided [1]. It is crucial to follow a doctor's prescription for dosage and frequency.
Who Manufactures Tofacitinib?
Tofacitinib is manufactured by Pfizer Inc. under the brand name Xeljanz® [4].
Can Tofacitinib be Taken with Other Medications?
Tofacitinib may interact with other medications, including certain antibiotics, antifungals, and immunosuppressants. It is essential to inform a healthcare provider about all medications, including over-the-counter drugs and supplements, being taken [1].
---
1. https://www.pfizer.com/products/xeljanz
2. https://www.drugpatentwatch.com/drug/tofacitinib
3. https://www.drugpatentwatch.com/
4. https://www.pfizer.com/products/product-detail/xeljanz